Empirical Financial Services LLC d.b.a. Empirical Wealth Management Makes New Investment in Phibro Animal Health Corporation (NASDAQ:PAHC)

Key Points

• Empirical Financial Services LLC made a new investment in Phibro Animal Health Corporation (NASDAQ:PAHC), purchasing 10,486 shares valued at approximately $224,000 during the 1st quarter.
• Phibro Animal Health announced a quarterly dividend of $0.12 per share, with a yield of 1.8%, and a payout ratio of 61.54%.
• Analysts have varying ratings on Phibro Animal Health, with two analysts giving it a "buy" rating and the average target price set at $24.40.

Empirical Financial Services LLC d.b.a. Empirical Wealth Management purchased a new position in shares of Phibro Animal Health Corporation (NASDAQ:PAHC - Free Report) in the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 10,486 shares of the company's stock, valued at approximately $224,000.

A number of other hedge funds have also made changes to their positions in the stock. LPL Financial LLC lifted its holdings in Phibro Animal Health by 46.8% in the first quarter. LPL Financial LLC now owns 128,335 shares of the company's stock worth $2,741,000 after purchasing an additional 40,889 shares during the period. Navellier & Associates Inc. acquired a new position in shares of Phibro Animal Health in the 1st quarter valued at about $878,000. Cetera Investment Advisers increased its holdings in shares of Phibro Animal Health by 18.9% in the 1st quarter. Cetera Investment Advisers now owns 11,550 shares of the company's stock valued at $247,000 after purchasing an additional 1,840 shares during the period. Wakefield Asset Management LLLP increased its holdings in shares of Phibro Animal Health by 8.2% in the 1st quarter. Wakefield Asset Management LLLP now owns 52,550 shares of the company's stock valued at $1,122,000 after purchasing an additional 3,980 shares during the period. Finally, Universal Beteiligungs und Servicegesellschaft mbH acquired a new position in shares of Phibro Animal Health in the 1st quarter valued at about $331,000. Institutional investors and hedge funds own 99.34% of the company's stock.

Wall Street Analysts Forecast Growth

PAHC has been the subject of several research reports. BNP Paribas raised Phibro Animal Health to a "hold" rating in a research report on Monday, June 16th. BNP Paribas Exane upgraded Phibro Animal Health from an "underperform" rating to a "neutral" rating and set a $24.00 target price on the stock in a research note on Monday, June 16th. Wall Street Zen upgraded Phibro Animal Health from a "hold" rating to a "buy" rating in a research note on Friday, May 9th. JPMorgan Chase & Co. upgraded Phibro Animal Health from a "neutral" rating to an "overweight" rating and increased their price target for the company from $25.00 to $35.00 in a research note on Monday, July 7th. Finally, Morgan Stanley set a $26.00 price objective on Phibro Animal Health and gave the company an "equal weight" rating in a report on Wednesday, June 25th. Two equities research analysts have rated the stock with a sell rating, three have assigned a hold rating and two have assigned a buy rating to the company's stock. According to data from MarketBeat.com, the company currently has an average rating of "Hold" and an average target price of $24.40.

Phibro Animal Health Price Performance

NASDAQ PAHC traded up $0.76 during trading on Thursday, reaching $27.25. The company's stock had a trading volume of 128,761 shares, compared to its average volume of 258,104. The stock has a market capitalization of $1.10 billion, a PE ratio of 35.01, a P/E/G ratio of 0.45 and a beta of 0.80. The company has a debt-to-equity ratio of 2.67, a current ratio of 2.91 and a quick ratio of 1.23. The firm has a fifty day moving average of $26.86 and a 200 day moving average of $23.41. Phibro Animal Health Corporation has a one year low of $16.16 and a one year high of $31.80.

Phibro Animal Health (NASDAQ:PAHC - Get Free Report) last announced its quarterly earnings data on Wednesday, May 7th. The company reported $0.63 EPS for the quarter, beating the consensus estimate of $0.52 by $0.11. Phibro Animal Health had a return on equity of 30.51% and a net margin of 2.68%. The firm had revenue of $347.80 million for the quarter, compared to analyst estimates of $352.41 million. Analysts expect that Phibro Animal Health Corporation will post 1.95 EPS for the current fiscal year.

Phibro Animal Health Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, September 24th. Investors of record on Wednesday, September 3rd will be given a dividend of $0.12 per share. This represents a $0.48 dividend on an annualized basis and a yield of 1.8%. The ex-dividend date of this dividend is Wednesday, September 3rd. Phibro Animal Health's dividend payout ratio (DPR) is 61.54%.

Phibro Animal Health Company Profile

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.